Improving Outcomes for Esophageal Cancer using Proton Beam Therapy

International Journal of Radiation Oncology Biology Physics

Volumn 95, Issue 1, 2016, Pages 488-497

  Chuong, Michael D ^a   Hallemeier, Christopher L ^b   Jabbour, Salma K ^c   Yu, Jen ^a   Badiyan, Shahed ^a   Merrell, Kenneth W ^b   Mishra, Mark V ^a   Li, Heng ^e   Verma, Vivek ^d   Lin, Steven H ^e  

^a UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

^b MAYO CLINIC   (United States)

^c RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

^d UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^e UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COST EFFECTIVENESS; DISEASES; PHOTONS; PROTON BEAMS; RADIOTHERAPY; TOXICITY;

CRITICAL STRUCTURES; DOSE ESCALATION; ESOPHAGEAL CANCER; INTENSITY-MODULATED; MOTION MANAGEMENT; MYOCARDIAL INFARCTION; TECHNOLOGICAL ADVANCEMENT; THORACIC STRUCTURES;

PROTON BEAM THERAPY;

ANOREXIA; ARTICLE; ASPIRATION PNEUMONIA; CLINICAL TRIAL (TOPIC); COST EFFECTIVENESS ANALYSIS; DOSIMETRY; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGITIS; ESOPHAGUS CANCER; ESOPHAGUS HEMORRHAGE; FOUR DIMENSIONAL COMPUTED TOMOGRAPHY; HEMATOLOGIC DISEASE; HUMAN; INTENSITY MODULATED RADIATION THERAPY; META ANALYSIS (TOPIC); NAUSEA; OUTCOME ASSESSMENT; PHASE 2 CLINICAL TRIAL (TOPIC); POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROTON THERAPY; RADIATION DERMATITIS; RADIATION DOSE DISTRIBUTION; RADIATION DOSE ESCALATION; RADIATION PNEUMONIA; RANDOMIZED CONTROLLED TRIAL (TOPIC); RE-IRRADIATION; ADVERSE EFFECTS; COST BENEFIT ANALYSIS; ECONOMICS; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; HEART; LUNG; MOVEMENT (PHYSIOLOGY); ORGANS AT RISK; PHOTON; PROCEDURES; RADIATION RESPONSE; RADIATION SCATTERING; RADIOTHERAPY DOSAGE; RELATIVE BIOLOGIC EFFECTIVENESS; THERAPEUTIC USE; TREATMENT OUTCOME;

CLINICAL TRIALS AS TOPIC; COST-BENEFIT ANALYSIS; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; HEART; HUMANS; LUNG; MOVEMENT; ORGANS AT RISK; PHOTONS; PROTON THERAPY; RADIOTHERAPY DOSAGE; RADIOTHERAPY, INTENSITY-MODULATED; RE-IRRADIATION; RELATIVE BIOLOGICAL EFFECTIVENESS; SCATTERING, RADIATION; TREATMENT OUTCOME;

EID: 84963533301     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2015.11.043     Document Type: Review

References (64)

1. L.A. Torre, F. Bray, R.L. Siegel, and et al. Global cancer statistics, 2012 CA Cancer J Clin 65 2015 87 108
2. R.L. Siegel, K.D. Miller, and A. Jemal Cancer statistics, 2015 CA Cancer J Clin 65 2015 5 29
3. J. Shapiro, J.J. van Lanschot, M.C. Hulshof, and et al. Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): Long-term results of a randomised controlled trial Lancet Oncol 16 2015 1090 1098
4. A. Herskovic, K. Martz, M. al-Sarraf, and et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus N Engl J Med 326 1992 1593 1598
5. J. Wang, C. Wei, S.L. Tucker, and et al. Predictors of postoperative complications after trimodality therapy for esophageal cancer Int J Radiat Oncol Biol Phys 86 2013 885 891
6. S.L. Wang, Z. Liao, A.A. Vaporciyan, and et al. Investigation of clinical and dosimetric factors associated with postoperative pulmonary complications in esophageal cancer patients treated with concurrent chemoradiotherapy followed by surgery Int J Radiat Oncol Biol Phys 64 2006 692 699
7. M. Hatakenaka, M. Yonezawa, T. Nonoshita, and et al. Acute cardiac impairment associated with concurrent chemoradiotherapy for esophageal cancer: Magnetic resonance evaluation Int J Radiat Oncol Biol Phys 83 2012 e67 e73
8. I. Gayed, S. Gohar, Z. Liao, and et al. The clinical implications of myocardial perfusion abnormalities in patients with esophageal or lung cancer after chemoradiation therapy Int J Cardiovasc Imaging 25 2009 487 495
9. J.C. Beukema, P. van Luijk, J. Widder, and et al. Is cardiac toxicity a relevant issue in the radiation treatment of esophageal cancer? Radiother Oncol 114 2015 85 90
10. A. Chandra, T.M. Guerrero, H.H. Liu, and et al. Feasibility of using intensity-modulated radiotherapy to improve lung sparing in treatment planning for distal esophageal cancer Radiother Oncol 77 2005 247 253
11. T.P. Kole, O. Aghayere, J. Kwah, and et al. Comparison of heart and coronary artery doses associated with intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy for distal esophageal cancer Int J Radiat Oncol Biol Phys 83 2012 1580 1586
12. G. Nicolini, S. Ghosh-Laskar, S.K. Shrivastava, and et al. Volumetric modulation arc radiotherapy with flattening filter-free beams compared with static gantry IMRT and 3D conformal radiotherapy for advanced esophageal cancer: A feasibility study Int J Radiat Oncol Biol Phys 84 2012 553 560
13. S.H. Lin, L. Wang, B. Myles, and et al. Propensity score-based comparison of long-term outcomes with 3-dimensional conformal radiotherapy vs intensity-modulated radiotherapy for esophageal cancer Int J Radiat Oncol Biol Phys 84 2012 1078 1085
14. J. Freilich, S.E. Hoffe, K. Almhanna, and et al. Comparative outcomes for three-dimensional conformal versus intensity-modulated radiation therapy for esophageal cancer Dis Esophagus 28 2015 352 357
15. U. Isacsson, B. Lennernas, E. Grusell, and et al. Comparative treatment planning between proton and x-ray therapy in esophageal cancer Int J Radiat Oncol Biol Phys 41 1998 441 450
16. H. Makishima, H. Ishikawa, T. Terunuma, and et al. Comparison of adverse effects of proton and X-ray chemoradiotherapy for esophageal cancer using an adaptive dose-volume histogram analysis J Radiat Res 56 2015 568 576
17. X. Zhang, K.l. Zhao, T.M. Guerrero, and et al. Four-dimensional computed tomography-based treatment planning for intensity-modulated radiation therapy and proton therapy for distal esophageal cancer Int J Radiat Oncol Biol Phys 72 2008 278 287
18. C.W. Taylor, D. Bronnum, S.C. Darby, and et al. Cardiac dose estimates from Danish and Swedish breast cancer radiotherapy during 1977-2001 Radiother Oncol 100 2011 176 183
19. R.K. Funk, E.J. Tryggestad, B.D. Kazemba, and et al. Dosimetric comparison of imrt vs pencil-beam scanning proton therapy for distal esophageal cancer Int J Particle Ther 2 2015 360 361
20. J. Welsh, D. Gomez, M.B. Palmer, and et al. Intensity-modulated proton therapy further reduces normal tissue exposure during definitive therapy for locally advanced distal esophageal tumors: A dosimetric study Int J Radiat Oncol Biol Phys 81 2011 1336 1342
21. J. Yu, X. Zhang, L. Liao, and et al. Motion-robust intensity-modulated proton therapy for distal esophageal cancer Med Phys 2016 In Press
22. S. Mori, and G.T. Chen Quantification and visualization of charged particle range variations Int J Radiat Oncol Biol Phys 72 2008 268 277
23. S. Mori, J. Wolfgang, H.M. Lu, and et al. Quantitative assessment of range fluctuations in charged particle lung irradiation Int J Radiat Oncol Biol Phys 70 2008 253 261
24. B.P. Yaremko, T.M. Guerrero, M.F. McAleer, and et al. Determination of respiratory motion for distal esophagus cancer using four-dimensional computed tomography Int J Radiat Oncol Biol Phys 70 2008 145 153
25. J.Z. Wang, J.B. Li, W. Wang, and et al. Changes in tumour volume and motion during radiotherapy for thoracic oesophageal cancer Radiother Oncol 114 2015 201 205
26. C. Bert, N. Saito, A. Schmidt, and et al. Target motion tracking with a scanned particle beam Med Phys 34 2007 4768
27. J.Y. Chang, H. Li, X.R. Zhu, and et al. Clinical implementation of intensity modulated proton therapy for thoracic malignancies Int J Radiat Oncol Biol Phys 90 2014 809 818
28. T. Furukawa, T. Inaniwa, S. Sato, and et al. Moving target irradiation with fast rescanning and gating in particle therapy Med Phys 37 2010 4874
29. A.C. Knopf, T.S. Hong, and A. Lomax Scanned proton radiotherapy for mobile targets - the effectiveness of re-scanning in the context of different treatment planning approaches and for different motion characteristics Phys Med Biol 56 2011 7257 7271
30. Y. Li, L. Kardar, X. Li, and et al. On the interplay effects with proton scanning beams in stage III lung cancer Med Phys 41 2014 021721
31. S. Mori, T. Inaniwa, T. Furukawa, and et al. Amplitude-based gated phase-controlled rescanning in carbon-ion scanning beam treatment planning under irregular breathing conditions using lung and liver 4DCTs J Radiat Res 55 2014 948 958
32. S. Mori, S. Zenklusen, T. Inaniwa, and et al. Conformity and robustness of gated rescanned carbon ion pencil beam scanning of liver tumors at NIRS Radiother Oncol 111 2014 431 436
33. M. Riboldi, R. Orecchia, and G. Baroni Real-time tumour tracking in particle therapy: Technological developments and future perspectives Lancet Oncol 13 2012 e383 e391
34. A. Schätti, M. Zakova, D. Meer, and et al. Experimental verification of motion mitigation of discrete proton spot scanning by re-scanning Phys Med Biol 58 2013 8555 8572
35. J. Seco, D. Robertson, A. Trofimov, and et al. Breathing interplay effects during proton beam scanning: Simulation and statistical analysis Phys Med Biol 54 2009 N283 N294
36. W. Takahashi, S. Mori, M. Nakajima, and et al. Carbon-ion scanning lung treatment planning with respiratory-gated phase-controlled rescanning: Simulation study using 4-dimensional CT data Radiat Oncol 9 2014 1 9
37. X. Pan, X. Zhang, Y. Li, and et al. Impact of using different four-dimensional computed tomography data sets to design proton treatment plans for distal esophageal cancer Int J Radiat Oncol Biol Phys 73 2009 601 609
38. E.J. Tryggestad, C.J. Beltran, R.K. Funk, and et al. 4D robustness of proton pencil beam scanning for esophageal cancer using a GPU-based Monte Carlo dose engine Int J Particle Ther 2 2015 364 365
39. J. Yu, X. Zhang, L. Liao, and et al. Motion-robust intensity-modulated proton therapy for distal esophageal cancer Med Phys 2015 In press
40. S. Shibuya, Y. Takase, M. Watanabe, and et al. Usefulness of proton irradiation therapy as preoperative measure for esophageal cancer Dis Esoph 2 1989 99 104
41. M. Mizumoto, S. Sugahara, H. Nakayama, and et al. Clinical results of proton-beam therapy for locoregionally advanced esophageal cancer Strahlenther Onkol 186 2010 482 488
42. H. Ishikawa, T. Hashimoto, T. Moriwaki, and et al. Proton beam therapy combined with concurrent chemotherapy for esophageal cancer Anticancer Res 35 2015 1757 1762
43. S.H. Lin, R. Komaki, Z. Liao, and et al. Proton beam therapy and concurrent chemotherapy for esophageal cancer Int J Radiat Oncol Biol Phys 83 2012 e345 e351
44. J. Wang, C. Wei, S.L. Tucker, and et al. Predictors of postoperative complications after trimodality therapy for esophageal cancer Int J Radiat Oncol Biol Phys 86 2013 885 891
45. C.L. Hallemeier, M. Chuong, K.W. Merrell, and et al. Impact of Neoadjuvant Proton vs. Photon Chemoradiotherapy on Post-Operative Outcomes in Patients with Esophageal Cancer Treated with Trimodality Therapy: A Multi-Institutional Analysis Int J Particle Ther 2 2015 79 80
46. M. Chuong, N. Bhooshan, P.K. Allen, and et al. A Multi-Institutional Analysis of Acute Toxicity after Neoadjuvant Chemoradiation Using Photons or Protons in Trimodality Esophageal Cancer Patients Int J Particle Ther 2 2015 88 89
47. B.D. Minsky, T.F. Pajak, R.J. Ginsberg, and et al. INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: High-dose versus standard-dose radiation therapy J Clin Oncol 20 2002 1167 1174
48. Z. Zhang, Z. Liao, J. Jin, and et al. Dose-response relationship in locoregional control for patients with stage II-III esophageal cancer treated with concurrent chemotherapy and radiotherapy Int J Radiat Oncol Biol Phys 61 2005 656 664
49. L. He, P.K. Allen, A. Potter, and et al. Re-evaluating the optimal radiation dose for definitive chemoradiotherapy for esophageal squamous cell carcinoma J Thorac Oncol 9 2014 1398 1405
50. J.W. Welsh, S.N. Seyedin, W. Hofstetter, and et al. Prospective Phase 1/2 Clinical Trial: Evaluating Dose-Escalation for Esophageal Cancer Int J Radiat Oncol Biol Phys 93 2015 S12 S13
51. J. Chen, D. Li, T. Zhai, and et al. Phase 2 Study of Simultaneous Modulated Accelerated Radiation Therapy Combined With Chemotherapy for Esophageal Squamous Cell Carcinoma: Early Outcomes Int J Radiat Oncol Biol Phys 93 2015 S13
52. R. Shridhar, M. Chuong, J. Weber, and et al. Preoperative dose painting IMRT chemoradiation to 56 Gy in esophageal cancer doubles pathologic complete response rate without increasing toxicity Int J Radiat Oncol Biol Phys 84 2012 S42
53. J.I. Geh, S.J. Bond, S.M. Bentzen, and et al. Systematic overview of preoperative (neoadjuvant) chemoradiotherapy trials in oesophageal cancer: evidence of a radiation and chemotherapy dose response Radiother Oncol 78 2006 236 244
54. C. Chargari, J.C. Soria, and E. Deutsch Controversies and challenges regarding the impact of radiation therapy on survival Ann Oncol 24 2013 38 46
55. L. Bedenne, P. Michel, O. Bouche, and et al. Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102 J Clin Oncol 25 2007 1160 1168
56. M. Stahl, M. Stuschke, N. Lehmann, and et al. Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus J Clin Oncol 23 2005 2310 2317
57. P. van Hagen, M.C. Hulshof, J.J. van Lanschot, and et al. Preoperative chemoradiotherapy for esophageal or junctional cancer N Engl J Med 366 2012 2074 2084
58. V. Oppedijk, A. van der Gaast, J.J. van Lanschot, and et al. Patterns of recurrence after surgery alone versus preoperative chemoradiotherapy and surgery in the CROSS trials J Clin Oncol 32 2014 385 391
59. S. Koyama, H. Tsujii, H. Yokota, and et al. Proton beam therapy for patients with esophageal carcinoma Jpn J Clin Oncol 24 1994 144 153
60. S. Sugahara, K. Tokuuye, T. Okumura, and et al. Clinical results of proton beam therapy for cancer of the esophagus Int J Radiat Oncol Biol Phys 61 2005 76 84
61. M. Mizumoto, S. Sugahara, T. Okumura, and et al. Hyperfractionated concomitant boost proton beam therapy for esophageal carcinoma Int J Radiat Oncol Biol Phys 81 2011 e601 e606
62. J.P. Plastaras, A.T. Berman, and G.M. Freedman Special cases for proton beam radiotherapy: re-irradiation, lymphoma, and breast cancer Semin Oncol 41 2014 807 819
63. Decision analytic modelling in the economic evaluation of health technologies A consensus statement. Consensus Conference on Guidelines on Economic Modelling in Health Technology Assessment Pharmacoeconomics 17 2000 443 444
64. P.A. Ubel, R.A. Hirth, M.E. Chernew, and et al. What is the price of life and why doesn't it increase at the rate of inflation? Arch Intern Med 163 2003 1637 1641